AHR-mediated immunomodulation: The role of altered gene transcription

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 746-760

  Kerkvliet, Nancy I ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BENZIMIDAZOLE DERIVATIVE; BILIRUBIN; FLAVONE; HALOGENATED HYDROCARBON; LIPOXIN A; POLYCYCLIC AROMATIC HYDROCARBON; TRYPTOPHAN;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ENVIRONMENTAL POLLUTANTS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC;

EID: 59149104736     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.11.021     Document Type: Article

References (91)

1. Kerkvliet N.I. Immunotoxicology of dioxins and related chemicals. In: Schecter A. (Ed). Dioxins and health (1994), Plenum Press 199-225
2. Ward E.C., Murray M.J., and Dean J.H. Immunotoxicity of Nonhalogenated polycyclic aromatic hydrocarbons. In: Dean J.H., Luster M.I., Munson A.E., and Amos H. (Eds). Immunotoxicology and immunopharmacology (1985), Raven Press 291-313
3. Davila D.R., Davis D.P., Campbell K., Cambier J.C., Zigmond L.A., and Burchiel S.W. Role of alterations in Ca(2+)-associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbons. J Toxicol Environ Health 45 (1995) 101-126
4. Mann K.K., Matulka R.A., Lawrence B.P., Kerkvliet N.I., and Sherr D.H. The role of cytochrome P-450 enzymes in 7,12-dimethylbenz[a]anthracene-induced apoptosis. Toxicol Appl Pharmacol 161 (1999) 10-22
5. Lawrence B.P., and Kerkvliet N.I. Immune modulation by TCDD and related polyhalogenated aromatic hydrocarbons. In: Luebke R., House R., and Kimber I. (Eds). Immunotoxicology and immunopharmacology. 3rd edition (2007), CRC Press 239-258
6. Kerkvliet N.I., Steppan L.B., Smith B.B., Youngberg J.A., Henderson M.C., and Buhler D.R. Role of the Ah locus in suppression of cytotoxic T lymphocyte (CTL) activity by halogenated aromatic hydrocarbons (PCBs and TCDD): structure-activity relationships and effects in congenic C57Bl/6 mice. Fund Appl Toxicol 14 (1990) 532-541
7. Warren T.K., Mitchell K.A., and Lawrence B.P. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56 (2000) 114-123
8. Vorderstrasse B.A., Steppan L.B., Silverstone A.E., and Kerkvliet N.I. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171 (2001) 157-164
9. Lawrence B.P., Roberts A.D., Neumiller J.J., Cundiff J.A., and Woodland D.L. Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T cells in the lung. J Immunol 177 (2006) 5819-5828
10. Lawrence B.P., Warren T.K., and Luong H. Fewer T lymphocytes and decreased pulmonary influenza virus burden in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Toxicol Environ Health A 61 (2000) 39-53
11. Prell R.A., Oughton J.A., and Kerkvliet N.I. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int J Immunopharmacol 17 (1995) 951-961
12. Kerkvliet N.I., Baecher-Steppan L., Shepherd D.M., Vorderstrasse B.A., Oughton J.A., and DeKrey D.J. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 157 (1996) 2310-2319
13. Clark G.C., Taylor M.J., Tritscher A.M., and Lucier G.W. Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus. Toxicol Appl Pharmacol 111 (1991) 422-431
14. Sun Y.V., Boverhof D.R., Bergoon L.D., Fielden M.R., and Zacharewski T.R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res 32 (2004) 4512-4523
15. Bunger MK, Glover E, Moran SM, Walisser JA, Lahvis GP, Hsu EL, et al. Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA binding domain of the aryl hydrocarbon receptor. Tox Sci 2008 [Epub ahead of print].
16. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
17. Vos J.G., Kreeftenberg J.G., Engel H.W., Minderhoud A., and Van Noorle Jansen L.M. Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 9 (1978) 75-86
18. Tang X., Metzger D., Leeman S., and Amar S. LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: evidence for LITAF-dependent LPS signaling pathways. Proc Natl Acad Sci USA 103 (2006) 13777-13782
19. Birnbaum L.S., McDonald M.M., Blair P.C., Clark A.M., and Harris M.W. Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah locus. Fundam Appl Toxicol 15 (1990) 186-200
20. Ackermann M.F., Gasiewicz T.A., Lamm K.R., Germolec D.R., and Luster M.I. Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 101 (1989) 470-480
21. Kerkvliet N.I., and Oughton J.A. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 (1993) 248-257
22. Choi J.-Y., Oughton J.A., and Kerkvliet N.I. Functional alterations in CD11b+Gr-1+ cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int Immunopharm 3 (2003) 553-570
23. Teske S., Bohn A.A., Regal J.F., Neumiller J.J., and Lawrence B.P. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. Am J Physiol Lung Cell Mol Physiol 289 (2005) L111-L124
24. Teske S., Bohn A.A., Hogaboam J.P., and Lawrence B.P. Aryl hydrocarbon receptor targets pathways extrinsic to bone marrow cells to enhance neutrophil recruitment during influenza virus infection. Toxicol Sci 102 (2008) 89-99
25. Vogel C.F., Nishimura N., Sciullo E., Wong P., Li W., and Matsumura F. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem Biophys 461 (2007) 169-175
26. Ellson C.D., Davidson K., Ferguson G.J., O'Connor R., Stephens L.R., and Hawkins P.T. Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med 203 (2006) 1927-1937
27. Sancho-Shimizu V., and Malo D. Sequencing, expression, and functional analyses support the candidacy of Ncf2 in susceptibility to Salmonella typhimurium infection in wild-derived mice. J Immunol 176 (2006) 6954-6961
28. Moos A.B., Oughton J.A., and Kerkvliet N.I. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tumor necrosis factor (TNF) production by peritoneal cells. Toxicol Lett 90 (1997) 145-153
29. Neff-LaFord H., Vorderstrasse B., and Lawrence B.P. Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol 226 (2003) 54-64
30. Cheon H., Woo Y.S., Lee J.Y., Kim H.S., Kim H.J., Cho S., et al. Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages. Exp Mol Med 39 (2007) 524-534
31. Monteiro P., Gilot D., Le Ferrec E., Rauch C., Lagadic-Gossmann D., and Fardel O. Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol 73 (2008) 769-777
32. Vogel C.F., Sciullo E., and Matsumura F. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun 363 (2007) 722-726
33. Vogel C.F., Sciullo E., Li W., Wong P., Lazennec G., and Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 21 (2007) 2941-2955
34. Vorderstrasse B.A., and Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol Appl Pharmacol 171 (2001) 117-125
35. Vorderstrasse B.A., Dearstyne E.A., and Kerkvliet N.I. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells. Toxicol Sci 72 (2003) 103-112
36. Ruby C.E., Funatake C.J., and Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) directly enhances the maturation and apoptosis of dendritic cells in vitro. J Immunotoxicol 1 (2005) 159-166
37. Ruby C.E., Leid M., and Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-α and anti-CD40-induced activation of NF-κB/Rel in dendritic cells: p50 homodimer activation is not affected. Mol Pharmacol 62 (2002) 722-728
38. McGeachy M.J., and Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 28 (2008) 445-453
39. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 (2008) 775-787
40. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 (2008) 65-71
41. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 (2008) 106-109
42. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesions. J Exp Med 199 (2004) 1479-1489
43. Li B., Chang T., Larson A., and Ding J. Identification of mRNAs expressed in tumor-infiltrating lymphocytes by a strategy for rapid and high throughput screening. Gene 255 (2000) 273-279
44. Luebke R.W., Copeland C.B., Daniels M., Lambert A.L., and Gilmour M.I. Suppression of allergic immune responses to house dust mite (HDM) in rats exposed to 2,3,7,8-TCDD. Toxicol Sci 62 (2001) 71-79
45. Prell R.A., and Kerkvliet N.I. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the alloantibody response to the P815 mastocytoma. J Immunol 158 (1997) 2695-2703
46. Prell R.A., Dearstyne E., Steppan L.G., Vella A.T., and Kerkvliet N.I. CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis. Toxicol Appl Pharmacol 166 (2000) 214-221
47. Jeon M.S., and Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 165 (2000) 6975-6983
48. Kerkvliet N.I., Shepherd D.M., and Baecher-Steppan L. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 185 (2002) 146-152
49. + cells with characteristics of regulatory T cells. J Immunol 175 (2005) 4184-4188
50. Marshall N.B., Vorachek W.R., Steppan L.B., Mourich D.V., and Kerkvliet N.I. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 181 (2008) 2382-2391
51. Funatake C.J., Marshall N.B., and Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation of alloreactive CD8+ T cells toward a regulatory T cell phenotype by a mechanism that is dependent on aryl hydrocarbon receptor in CD4+ T cells. J Immunotoxicol 5 (2008) 81-91
52. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., and Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88 (1991) 9543-9547
53. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., and Kishimoto T. Aryl hydrocarbon receptor regulated Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105 (2008) 9721-9726
54. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43 (2003) 309-334
55. Fallarino F., Grohmann U., You S., McGrath B.C., Cavener D.R., Vacca C., et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor d-chain and induce a regulatory phenotype in naïve T cells. J Immunol 176 (2006) 6752-6761
56. Frumento G., Rotondo R., Tonetti M., Damont G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196 (2002) 459-468
57. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 9 (2002) 1069-1077
58. Terness P., Bauer T.M., Röse L., Dufter C., Watzlik A., Simon H., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196 (2002) 447-457
59. Belladonna M.L., Grohmann U., Guidetti P., Volpi C., Bianchi R., Fioretti M.C., et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol 177 (2006) 130-137
60. Platten M., Ho P.P., Youssef S., Fontoura P., Garren H., Hur E.M., et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310 (2005) 850-855
61. Rannug U., Rannug A., Sjoberg U., Li H., Westerholm R., and Bergman J. Structure eludciation of two tryptophan-derived high affinity Ah receptor ligands. Chem Biol 2 (1995) 841-845
62. Schwartz T. Regulatory T cells induced by ultraviolet irradiation. Int Arch Allergy Immunol 1137 (2005) 187-193
63. Gorman S., Tan J.W.Y., Yerkovich S.T., Finaly-Jones J.J., and Hart P.H. CD4+ T cells in lymph nodes of UVB-irradiated mice suppress immune responses to new antigens both in vitro and in vivo. J Invest Dermatol 127 (2006) 915-927
64. Nguyen L.P., and Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21 (2008) 102-116
65. Diani-Moore S., Labitzke E., Brown R., Garvin A., Wong L., and Rifkind A.B. Sunlight generates multiple tryptophan photoproducts eliciting high efficacy CYP1A induction in chick hepatocytes and in vivo. Toxicol Sci 90 (2006) 96-110
66. Hu W., Sorrentino C., Denison M.S., Kolaja K., and Fielden M.R. Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol 71 (2007) 1475-1486
67. Herrmann M.L., Schleyerbach R., and Kirschbaum B.J. Leflunomide: an immunomodulatory drug fo the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology 47 (2000) 273-289
68. Williamson R.A., Yea C.M., Robson P.A., Curnock A.P., Gadher S., Hambleton A.B., et al. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J Biol Chem 270 (1995) 22467-22472
69. Demitrova P., Skapenko A., Herrmann M.L., Schleyerbach R., Kalden J.R., and Schulze-Koops H. Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol 169 (2002) 3392-3399
70. Weigmann B., Jarman E.R., Sudowe S., Bros M., Knop J., and Reske-Kunz A.B. Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity. J Invest Dermatol 126 (2006) 1524-1533
71. Negishi T., Kato Y., Ooneda O., Mimura J., Takada T., Hidenori M., et al. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. J Immunol 175 (2005) 7348-7356
72. Morales J.L., Krzeminski J., Amin S., and Perdew G.H. Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2-phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists. Chem Res Toxicol 21 (2008) 472-482
73. Lawrence B.P., Denison M.S., Novak H., Vorderstrasse B.A., Harrer N., Neruda W., et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 112 (2008) 1158-1165
74. Hauben E., Gregori S., Draghici E., Migliavacca B., Olivieri S., Woisetschläger M., et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112 (2008) 1214-1222
75. Zhang S., Qin C., and Safe S.H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Perspect 111 (2003) 1877-1882
76. Verdrengh M., Jonsson I.M., Holmdahl R., and Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res 52 (2003) 341-346
77. Widyarini S., Spinks N., Husband A.J., and Reeve V.E. Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation. Photochem Photobiol 74 (2001) 465-470
78. Cooke P.S., Selvlaraj V., and Yellalyi S. Genistein, estrogen receptors, and the acquired immune response. J Nutr 136 (2006) 704-708
79. Liu Y., Li P., Lu J., Xiong W., Oger J., Tetzlaff W., et al. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalitis. J Immunol 181 (2008) 1887-1897
80. Lee S.S., Gao W., Mazzola S., Thomas M.N., Csizmadia E., Otterbein L.E., et al. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 21 (2007) 3450-3457
81. Schaldach C.M., Riby J., and Bjeldanes L.F. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38 (1999) 7594-7600
82. Machado F.S., and Aliberti J. Role of lipoxin in the modulation of immune response during infection. Int Immunopharmacol 8 (2008) 1316-1319
83. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 12 (2006) 330-339
84. Boverhof D.R., Tam E., Harney S., Crawford R.B., Kaminski N.E., and Zacharewski T.R. 2,3,7, 8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Mol Pharmacol 66 (2004) 1662-1670
85. Mimura J., Yamashita K., Nakamura K., Morita M., Takagi T.N., Nakao K., et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2 (1997) 645-654
86. Fernandez-Salguero P., Pineau T., Hilbert D.M., Mc Phail T., Lee S.S.T., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995) 722-726
87. Fernandez-Salguero P.M., Ward J.M., Sundberg J.P., and Gonzalez F.J. Lesions of aryl-hydrocarbon receptor deficient mice. Vet Pathol 34 (1997) 605-614
88. Hundeiker C., Pineau T., Cassar G., Betensky R.A., Gleichmann E., and Esser C. Thymocyte development in AHR-receptor-deficient mice is refractory to TCDD-inducible changes. Int J Immunopharmacol 21 (1999) 841-859
89. Rodriquez-Sosa M., Elizondo G., Lopez-Duran R.M., Rivera I., Gonzalez F.J., and Vega L. Over-production of IFN-g and IL-12 in AhR-null mice. FEBS Lett 579 (2005) 6403-6410
90. Shi L.Z., Faith N.G., Nakayama Y., Suresh M., Steinberg H., and Czuprynski C.J. The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J Immunol 179 (2007) 6952-6962
91. Thatcher T.H., Maggirwar S.B., Baglole C.J., Lakatos H.F., Gasiewicz T.A., Phipps R.P., et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor -kB component Relb. Am J Pathol 170 (2007) 855-864